TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) Investor Files Lawsuit Over Alleged Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By Bristol-Myers Squibb

  • If you purchased shares of Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) prior to June 29, 2012, and currently hold any of those NASDAQ:AMLN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

July 9, 2012 (Shareholders Foundation) -- An investor in NASDAQ:AMLN shares filed a lawsuit in State Court in effort to block the proposed takeover of Amylin Pharmaceuticals, Inc. at $31 per NASDAQ:AMLN share. The plaintiff alleges that certain directors of Amylin Pharmaceuticals, Inc. breached their fiduciary duties owed NASDAQ:AMLN investors arising out of the attempt to sell the c...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: